Limiting the number of available drug concentrations is a standard strategy to decrease the potential for error. I am interested in those institutions that do not stock heparin in either the 10,000 and 20,000 unit/mL concentrations. If you have eliminated these high concentrations, what were the barriers you had to overcome? Examples: higher concentrations are need for dialysis machines or needed for SQ prophylactic doses of heparin in bariatric patients.
If you have successfully overcome barriers to removing these highly concentrated forms of heparin, I would appreciate if you would respond in this forum or send me a separate email at email@example.com. I would like to talk with you about how you dealt with this challenge.